AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 72 min read$ARCB

Stipp Janice E sold $694K of ARCB

Stipp Janice E sold 5,000 shares of ARCBEST CORP /TX/ (ARCB) at an average of $138.71 ($137.46–$139.20, $0.69M total) across 2 trades on 2026-08-06.

Original reporting
SEC EDGAR · Stipp Janice E
Published Aug 7, 2026, 7:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 7:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ARCB
Neutral
medium confidence
Mentioned
$ARCB
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARCBNeutralLow
01

Why it matters

The disclosure updates the record of insider ownership and may influence short-term sentiment, but it does not provide new information about ARCB’s business, guidance, or risk factors.

02

Market read

Traders may note the insider sale for sentiment, but there is no fundamental catalyst in the text to drive a durable repricing.

03

What to watch

The article does not state the insider’s total compensation, tax situation, or whether other planned sales occurred; absence of a 10b5-1 plan can increase speculation but is not proof of information advantage.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-07 after-hours; transaction dated 2026-08-06

Background

The article is a SEC Form 4 insider transaction disclosure for ARCB director Stipp Janice E.

Company-level read

Ticker impact

$ARCBNeutralMedium confidence
Context

ARCB director Stipp Janice E sold 5,000 shares in open-market transactions at about $137.46 to $139.20 per share.

Expected impact

Likely limited near-term impact; any effect would be small and short-lived unless accompanied by other news.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and no accompanying company-specific operational or financial update in the text.

Market effects

Sector

No sector read-through is provided; this is company-specific insider activity only.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales can be routine liquidity events (taxes, diversification) and may not reflect bearish expectations, especially without any other negative company news here.

Key entities

  • issuer
    ARCBEST CORP /TX/

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Stipp Janice E

    Director who sold 5,000 shares of ARCB on 2026-08-06.

Read at source← All news

Related articles

AUG 5
$ARCBMed

ArcBest’s Q2 Earnings Call: Our Top 5 Analyst Questions

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, and adjusted EPS of $2.38 versus $2.26 expected. Adjusted EBITDA was $115M versus $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, with sales volumes down 2.8% YoY. Management cited pricing discipline, efficiency gains, and noted no broad industrial demand inflection.

financialcontent.com4 min
AUG 1
$ARCBMed

ARCB Q2 Deep Dive: Restructuring and Digital Initiatives Take Center Stage Amid Market Challenges

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, with adjusted EPS of $2.38 vs $2.26 and adjusted EBITDA of $115M vs $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, and sales volumes declined 2.8% YoY. The company outlined restructuring and ArcBestView digital initiatives, targeting $40M annualized cost savings and growth in managed solutions.

yahoo.com6 min
JUL 31
$ARCBMed

ArcBest Q2 Earnings Call Highlights

The company expects the initiatives to generate about $40 million in annualized cost savings. Chief Financial Officer Matt Beasley said ArcBest recognized about $2 million of savings in the second quarter and expects approximately $6 million in the third quarter. The company expects to reach the full $10 million quarterly run rate by the first quarter of 2027. About 75% of the $40 million in savings is associated with the asset-based business.

yahoo.com5 min
JUL 31
$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

yahoo.com7 min
JUL 30
$ARCBMedAI 8/10

ArcBest’s Q2 a step on path to recovery

ArcBest's second-quarter results showed operational improvements in both of its business segments. It is benefitting from heavier shipment weights on the asset-based side of the house while cost initiatives have pushed its logistics offering back into profitability. Shipment weights increasing as TL freight returns ArcBest's (NASDAQ: ARCB) asset-based unit, which includes less-than-truckload subsidiary ABF Freight, reported a 10% y/y increase in revenue to $784 million.

yahoo.com4 min
JUL 29
$ARCBMed

ArcBest reports second quarter loss, affected by restructuring costs | Arkansas Democrat Gazette

ArcBest reported a Q2 GAAP loss of $13.8 million, or 62 cents per share, versus a year-ago profit of $25.8 million, or $1.12 per share. Revenue rose to $1.18 billion from $1.02 billion. Non-GAAP net income was $53.6 million, or $2.38 per diluted share. The results were tied to restructuring costs from a July 16 plan and included $40 million annualized savings.

arkansasonline.com6 min